MAPT and Mental deterioration: Notably, cross-sectional cognitive performance was worst in the p-tau+/BD-tau+ followed by the p-tau+/BD-tau- cases, meaning that those with abnormal levels of both plasma p-tau and BD-tau are at much higher odds of cognitive decline in the short term.